Delisting Becton Dickinson Alaris® Signature Dedicated Pump Sets (ICN 2413)
Important Customer Notice Delisting
Ref: 2024/2413
ICN Number: 2413
Change:
- Becton Dickinson (BD) has advised there will be a discontinuation of the Alaris® SE infusion pump sets by December 2024.
- 12 BD sets are affected and will gradually be delisted from the catalogue once the stock has depleted.
- FSB272 is already suspended and will be removed from the catalogue.
- Please note six of the sets will be discontinued by June 2024:
Affected Products | Supplier Code | Alternative |
FSB272 | 72103-0006 | FSB854 |
FSB1068 | 72923E-0006 | FSB866 |
FSB1188 | 11499817-09 | FKA862 |
FSB267 | 72313-0006 | FKA866 |
FSB2550 | 72304B | FKA866 |
FSB270 | 72923-0006 | FSB2540 |
- The remaining six codes stock is available subject to intermittent supply until November 2024:
Affected Products | Supplier Code | Alternative |
FKA880 | 72024EB | NA |
FKA862 | 71980B | NA |
FKA866 | 72504EB | NA |
FSB2540 | 72953B | NA |
FKA852 | 72643EB | NA |
FSB854 | 72103E-0006 | NA |
Impact:
- There are potential indirect alternatives for some of the products. These products are available to order through our online catalogue while stock is available.
- See our Downloads ▼ section to access the customer letter and product listing for further information on the affected product codes and potential alternatives.
- Customers are advised to review indirect alternatives; complete local stock take and consider looking at alternative pump options as the Beckton Dickinson signature pump will not be useable from December 2024.
Next Steps:
- Customers are advised to log into our website to view the potential indirect alternative products.
- Beckton Dickinson has provided Customers with a letter outlining the changes which is available in the download section.
- The indirect alternatives are also from the range being discontinued and are available while stocks last.
- If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor
Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.